(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 39% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 223.65%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Zai Lab's revenue in 2025 is $418,326,000.On average, 4 Wall Street analysts forecast ZLAB's revenue for 2025 to be $609,916,760,674, with the lowest ZLAB revenue forecast at $607,673,510,372, and the highest ZLAB revenue forecast at $614,615,871,076. On average, 4 Wall Street analysts forecast ZLAB's revenue for 2026 to be $862,624,114,019, with the lowest ZLAB revenue forecast at $824,774,146,512, and the highest ZLAB revenue forecast at $920,730,588,368.
In 2027, ZLAB is forecast to generate $1,164,533,279,366 in revenue, with the lowest revenue forecast at $1,144,014,264,510 and the highest revenue forecast at $1,185,052,294,222.